GeNose, the locally developed COVID-19 breathalyzer, has been approved for use at 21 airports across the country with plans to expand to other airports, the transportation minister has said.
“We are going to use GeNose in nearly 100 airports, so it can cover the eastern Indonesia region, too,” minister Budi Karya Sumadi stated in a press release on Saturday.
The government started trialing GeNose in March at several airports for direct testing of airport and airline staff. Direct trials for passengers started earlier this month, when the international airports in Bandung, Surabaya, Yogyakarta and Palembang adopted GeNose for testing domestic passengers.
The latest airports to offer the newly approved COVID-19 breath test includes Indonesia’s second busiest airport, I Gusti Ngurah Rai International Airport...
Starting from IDR 55,000/month